Anupam Rasayan Signs LoI Worth $95 Million With MNC Firm

Chemicals maker Anupam Rasayan on Monday announced it has signed a Letter of Intent (LoI) worth USD 95 million (about Rs 700 crore) with a multinational crop protection firm for supply of a new life science related active ingredient.

The company, in a statement, said it will enter into a long-term contract to supply this life science-related speciality chemical product for the next five years.

This new molecule is in addition to the existing product portfolio with this customer, it added.

Speaking about the development, Anupam Rasayan Managing Director Anand Desai said this LoI is in line with the company's strategy of value re-engineering to manufacture high-value products for medium to large volumes.

This LoI further expands the company's high-value product portfolio with major global players, he said.

So far in the 2021-22 fiscal, Anupam Rasayan has signed LoI worth Rs 1,800 crore and contracts worth Rs 820 crore, taking the total contracts and LoIs signed to Rs 2,620 crore, he added.

Desai said, "These orders demonstrate firm revenue visibility for growth in the coming years through the commercialisation of new molecules."

Anupam Rasayan is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. It makes products for over 66 domestic and global customers, including 23 MNCs.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor